Related Experiment Video
Updated: Aug 9, 2026

Measuring Ascending Aortic Stiffness In Vivo in Mice Using Ultrasound
Published on: December 2, 2014
Simvastatin improves arterial compliance in the lower limb but not in the aorta
1Baker Medical Research Institute, POB 6492 St. Kilda Road, Vic. 8008, Melbourne, Australia.
Insights
Lowering low-density lipoprotein (LDL) cholesterol with simvastatin improved peripheral arterial compliance, indicated by reduced peripheral pulse wave velocity (PWV). Central arterial compliance and systemic arterial compliance (SAC) were not significantly affected.
Area of Science:
- Cardiovascular Medicine
- Pharmacology
- Vascular Physiology
Background:
- Cardiovascular risk factors, including elevated low-density lipoprotein (LDL) cholesterol, can negatively impact arterial compliance.
- The precise effect of reducing LDL cholesterol on arterial distensibility remains uncertain, with previous studies showing minimal impact.
Purpose of the Study:
- To investigate the effect of lowering LDL cholesterol on systemic arterial compliance (SAC) and pulse wave velocities (PWV).
Main Methods:
- Twenty hypercholesterolemic subjects were randomized to receive either simvastatin (20 or 40 mg daily) or a placebo for 4 weeks.
- Arterial function was assessed by measuring systemic arterial compliance (SAC) and central (aorto-femoral) and peripheral (femoral-posterior tibial) pulse wave velocities (PWV).
Main Results:
- Simvastatin significantly reduced LDL cholesterol by 39%, plasma triglycerides by 18%, and increased high-density lipoprotein (HDL) cholesterol by 12%.
- Peripheral PWV showed a significant improvement (greater compliance) after simvastatin treatment (P<0.03).
- No significant changes were observed in systemic arterial compliance (SAC) or central PWV.
Conclusions:
- LDL cholesterol lowering with simvastatin improved peripheral arterial compliance, likely due to the muscular nature of the peripheral arterial bed.
- Central arterial compliance and systemic arterial compliance, reflecting the elastic aorta, were not influenced by LDL reduction.
Unlabelled:
Several cardiovascular risk factors adversely affect arterial compliance or the distensibility of large arteries. The role of raised low-density lipoproteins (LDL) cholesterol is uncertain, most studies having shown little effect. We, therefore, investigated whether lowering LDL would improve arterial compliance. Twenty hypercholesterolemic subjects (LDL cholesterol 4.95+/-1.11 mmol/l) were randomized to simvastatin (20 or 40 mg daily) or placebo, each for 4 weeks. Arterial function was assessed at the end of the placebo and simvastatin periods, systemic arterial compliance (SAC) and pulse wave velocities (PWV) centrally (aorto-femoral) and peripherally (femoral-posterior tibial).
Results:
Lipoproteins (LDL) cholesterol was reduced similarly with 20 and 40 mg simvastatin (ten subjects each dose) and data were pooled. Lipoproteins (LDL) cholesterol fell 39%, plasma triglyceride fell 18% and high-density lipoprotein (HDL) cholesterol rose 12%, all significant. Systemic arterial compliance (SAC) and central PWV did not change significantly but peripheral PWV showed evidence of greater compliance after simvastatin (10.1+/-1.3 vs. 9.4+/-1.3 m/s with placebo and simvastatin, P<0.03), distensibility being inversely related to PWV. Improvement in PWV was greatest in those with poorest baseline values, r=0.50; P<0.02.
Conclusion:
Peripheral PWV was alone improved with LDL lowering probably because of the muscularity of that arterial bed; central PWV and SAC (in the elastic aorta) were not influenced.
Related Concept Videos
Arteries of Lower Limbs
Aortic Regurgitation III: Medical Management
Atherosclerosis III: Management
Atherosclerosis IV: Nursing Management
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Peripheral Artery Disease III: Interprofessional Care

